Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$211.93 - $241.33 $2.08 Million - $2.37 Million
-9,835 Reduced 21.71%
35,459 $8.56 Million
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $1.63 Million - $1.97 Million
7,648 Added 20.32%
45,294 $10.4 Million
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $1.72 Million - $2.1 Million
-8,443 Reduced 18.32%
37,646 $8.86 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $1.64 Million - $2.1 Million
7,998 Added 21.0%
46,089 $9.28 Million
Q2 2022

Aug 15, 2022

BUY
$213.86 - $277.87 $970,496 - $1.26 Million
4,538 Added 13.52%
38,091 $8.92 Million
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $1.36 Million - $1.56 Million
5,238 Added 18.5%
33,553 $8.85 Million
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $1.14 Million - $1.32 Million
4,212 Added 17.48%
28,315 $8.9 Million
Q3 2021

Nov 12, 2021

BUY
$274.82 - $308.34 $530,127 - $594,787
1,929 Added 8.7%
24,103 $6.78 Million
Q2 2021

Aug 13, 2021

BUY
$251.87 - $278.14 $371,760 - $410,534
1,476 Added 7.13%
22,174 $6.12 Million
Q1 2021

May 14, 2021

BUY
$204.88 - $255.03 $1.03 Million - $1.29 Million
5,048 Added 32.26%
20,698 $5.28 Million
Q4 2020

Feb 08, 2021

BUY
$186.91 - $214.42 $25,232 - $28,946
135 Added 0.87%
15,650 $3.19 Million
Q3 2020

Nov 12, 2020

SELL
$167.03 - $201.3 $208,787 - $251,625
-1,250 Reduced 7.46%
15,515 $2.92 Million
Q2 2020

Jul 17, 2020

SELL
$113.31 - $182.44 $211,549 - $340,615
-1,867 Reduced 10.02%
16,765 $2.78 Million
Q1 2020

May 12, 2020

BUY
$104.32 - $195.28 $175,570 - $328,656
1,683 Added 9.93%
18,632 $2.36 Million
Q4 2019

Feb 11, 2020

BUY
$163.48 - $173.61 $2.35 Million - $2.5 Million
14,387 Added 561.55%
16,949 $2.87 Million
Q3 2019

Nov 13, 2019

SELL
$159.77 - $178.1 $87,234 - $97,242
-546 Reduced 17.57%
2,562 $431,000
Q2 2019

Aug 12, 2019

SELL
$144.16 - $172.9 $40,220 - $48,239
-279 Reduced 8.24%
3,108 $538,000
Q1 2019

May 08, 2019

SELL
$123.7 - $156.3 $1.99 Million - $2.51 Million
-16,074 Reduced 82.6%
3,387 $518,000
Q4 2018

Feb 14, 2019

SELL
$120.82 - $174.09 $200,802 - $289,337
-1,662 Reduced 7.87%
19,461 $2.46 Million
Q3 2018

Nov 14, 2018

BUY
$167.67 - $188.27 $3.17 Million - $3.56 Million
18,897 Added 848.92%
21,123 $3.67 Million
Q2 2018

Aug 14, 2018

SELL
$160.33 - $189.41 $39,280 - $46,405
-245 Reduced 9.92%
2,226 $400,000
Q1 2018

May 14, 2018

BUY
$161.53 - $178.11 $34,082 - $37,581
211 Added 9.34%
2,471 $412,000
Q4 2017

Feb 15, 2018

BUY
$147.99 - $163.95 $18,350 - $20,329
124 Added 5.81%
2,260 $360,000
Q3 2017

Nov 14, 2017

BUY
$149.47 - $160.56 $319,267 - $342,956
2,136
2,136 $322,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.